Kalcicur (Calcium)

Calcium, the active ingredient in Kalcicur, is a calcium supplement presented as an intravenous solution for intravenous use. It is employed to correct low serum calcium levels and to support bone mineralization in patients with hypocalcemia or calcium deficiency.\n\nGNH India supplies Kalcicur as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Kalcicur is used as a calcium supplement to address conditions related to low calcium levels.\n\n- Hypocalcemia: restores serum calcium concentrations to normal ranges.\n- Calcium deficiency: provides immediate calcium ions for metabolic needs.\n- Adjunct therapy for bone health: supports bone mineralization when oral supplementation is insufficient.

Adverse reactions may occur with intravenous calcium administration.\n\nCommon Side Effects:\n- Local irritation at infusion site\n- Nausea or vomiting\n- Transient hypotension\n- Flushing or warmth sensation\n- Mild headache\n\nSerious or Rare Side Effects:\n- Hypercalcemia leading to cardiac arrhythmia\n- Severe hypotension or bradycardia\n- Extravasation causing tissue necrosis\n- Allergic reaction or anaphylaxis\n- Cardiac arrest in extreme cases

Intravenous calcium requires careful monitoring and specific safety measures.\n\n- Serum calcium monitoring: check levels before, during, and after infusion.\n- Cardiac monitoring: observe heart rhythm and blood pressure throughout administration.\n- Infusion rate: avoid rapid infusion to reduce risk of hypotension and arrhythmia.\n- Renal impairment: adjust dose and monitor closely in patients with reduced kidney function.\n- Contraindication: do not use in patients with known hypercalcemia.\n- Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Calcium can interact with several medications, affecting efficacy or safety.\n\nMajor Interactions (Avoid):\n- Digoxin: increased risk of digitalis toxicity due to elevated calcium levels.\n- Calcium channel blockers: may potentiate hypotensive effects.\n\nModerate Interactions (Monitor Closely):\n- Loop diuretics: increase calcium excretion, may require dose adjustment.\n- Bisphosphonates: calcium can reduce absorption of bisphosphonates if given concurrently.\n- Antibiotics (e.g., tetracyclines, quinolones): calcium may form complexes, decreasing antibiotic effectiveness.